Health
Novavax COVID-19 vaccine demonstrates ~90% efficacy against SARS-CoV-2 – News-Medical.Net
The findings reveal that the two-dose regimen of the vaccine is almost 90% effective against severe acute respiratory syndrome…
In a recent study published in the New England Journal of Medicine, scientists have summarized the safety and efficacy profile of the full-length spike-based coronavirus disease 2019 (COVID-19) vaccine NVX-CoV2373 (Novavax). The findings reveal that the…
Continue Reading
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts